McKesson Other Operating Income or Expenses 2010-2024 | MCK
McKesson annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- McKesson other operating income or expenses for the quarter ending September 30, 2024 were $0.004B, a 100% increase year-over-year.
- McKesson other operating income or expenses for the twelve months ending September 30, 2024 were $-0.257B, a 4383.33% decline year-over-year.
- McKesson annual other operating income or expenses for 2024 were $-0.147B, a 1937.5% decline from 2023.
- McKesson annual other operating income or expenses for 2023 were $0.008B, a 102.92% decline from 2022.
- McKesson annual other operating income or expenses for 2022 were $-0.274B, a 96.55% decline from 2021.
McKesson Annual Other Operating Income or Expenses
(Millions of US $) |
| 2024 |
$-147 |
| 2023 |
$8 |
| 2022 |
$-274 |
| 2021 |
$-7,936 |
| 2020 |
$-82 |
| 2019 |
$-37 |
| 2018 |
$37 |
| 2017 |
$3,947 |
| 2016 |
$ |
| 2015 |
$-150 |
| 2014 |
$-68 |
| 2013 |
$-72 |
| 2012 |
$-149 |
| 2011 |
$-213 |
| 2010 |
$20 |
| 2009 |
$-493 |
McKesson Quarterly Other Operating Income or Expenses
(Millions of US $) |
| 2024-09-30 |
$4 |
| 2024-06-30 |
$-112 |
| 2024-03-31 |
$-149 |
| 2023-12-31 |
$0 |
| 2023-09-30 |
$2 |
| 2023-06-30 |
$0 |
| 2023-03-31 |
$3 |
| 2022-12-31 |
$1 |
| 2022-09-30 |
$9 |
| 2022-06-30 |
$-5 |
| 2022-03-31 |
$-81 |
| 2021-12-31 |
$-7 |
| 2021-09-30 |
$-112 |
| 2021-06-30 |
$-74 |
| 2021-03-31 |
|
| 2020-12-31 |
$-8,067 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$131 |
| 2020-03-31 |
$6,779 |
| 2019-12-31 |
$-2,535 |
| 2019-09-30 |
$-2,196 |
| 2019-06-30 |
$-2,130 |
| 2019-03-31 |
$6,182 |
| 2018-12-31 |
$-2,156 |
| 2018-09-30 |
$-2,033 |
| 2018-06-30 |
$-2,030 |
| 2018-03-31 |
$5,957 |
| 2017-12-31 |
$-1,984 |
| 2017-09-30 |
$-2,009 |
| 2017-06-30 |
$-1,927 |
| 2017-03-31 |
$9,749 |
| 2016-12-31 |
$-1,981 |
| 2016-09-30 |
$-1,886 |
| 2016-06-30 |
$-1,935 |
| 2016-03-31 |
|
| 2015-12-31 |
$-1,952 |
| 2015-09-30 |
$-1,890 |
| 2015-06-30 |
$-1,917 |
| 2015-03-31 |
$6,076 |
| 2014-12-31 |
$-2,098 |
| 2014-09-30 |
$-2,077 |
| 2014-06-30 |
$-2,051 |
| 2014-03-31 |
$3,899 |
| 2013-12-31 |
$-1,357 |
| 2013-09-30 |
$-1,335 |
| 2013-06-30 |
$-1,275 |
| 2013-03-31 |
$3,218 |
| 2012-12-31 |
$-1,147 |
| 2012-09-30 |
$-1,077 |
| 2012-06-30 |
$-1,066 |
| 2012-03-31 |
$3,131 |
| 2011-12-31 |
$-1,074 |
| 2011-09-30 |
$-1,169 |
| 2011-06-30 |
$-1,037 |
| 2011-03-31 |
$2,808 |
| 2010-12-31 |
$-1,154 |
| 2010-09-30 |
$-949 |
| 2010-06-30 |
$-918 |
| 2010-03-31 |
$2,678 |
| 2009-12-31 |
$-946 |
| 2009-09-30 |
$-868 |
| 2009-06-30 |
$-844 |
| 2009-03-31 |
$2,722 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$79.492B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
